JP2003534250A5 - - Google Patents

Download PDF

Info

Publication number
JP2003534250A5
JP2003534250A5 JP2001577979A JP2001577979A JP2003534250A5 JP 2003534250 A5 JP2003534250 A5 JP 2003534250A5 JP 2001577979 A JP2001577979 A JP 2001577979A JP 2001577979 A JP2001577979 A JP 2001577979A JP 2003534250 A5 JP2003534250 A5 JP 2003534250A5
Authority
JP
Japan
Prior art keywords
chemotaxin
apc
vmck
chemokine
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001577979A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003534250A (ja
JP4903342B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/012950 external-priority patent/WO2001080882A2/en
Publication of JP2003534250A publication Critical patent/JP2003534250A/ja
Publication of JP2003534250A5 publication Critical patent/JP2003534250A5/ja
Application granted granted Critical
Publication of JP4903342B2 publication Critical patent/JP4903342B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001577979A 2000-04-21 2001-04-20 免疫応答を誘発するための方法および組成物 Expired - Fee Related JP4903342B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19883900P 2000-04-21 2000-04-21
US60/198,839 2000-04-21
US83481401A 2001-04-12 2001-04-12
PCT/US2001/012950 WO2001080882A2 (en) 2000-04-21 2001-04-20 Methods and compositions for eliciting an immune response
US09/834,814 2001-04-20

Publications (3)

Publication Number Publication Date
JP2003534250A JP2003534250A (ja) 2003-11-18
JP2003534250A5 true JP2003534250A5 (enExample) 2008-05-29
JP4903342B2 JP4903342B2 (ja) 2012-03-28

Family

ID=26894197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001577979A Expired - Fee Related JP4903342B2 (ja) 2000-04-21 2001-04-20 免疫応答を誘発するための方法および組成物

Country Status (9)

Country Link
EP (1) EP1274454B1 (enExample)
JP (1) JP4903342B2 (enExample)
AT (1) ATE314088T1 (enExample)
AU (2) AU2001257148B2 (enExample)
CA (1) CA2406853C (enExample)
DE (1) DE60116280T2 (enExample)
DK (1) DK1274454T3 (enExample)
ES (1) ES2256232T3 (enExample)
WO (1) WO2001080882A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361329B2 (en) 2000-04-21 2008-04-22 Chemocentryx, Inc. Compositions for inducing an immune response
WO2003035106A1 (en) * 2001-10-24 2003-05-01 Chemocentryx Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen
AU2008317495B2 (en) 2007-08-02 2013-08-01 Novimmune S.A. Anti-RANTES antibodies and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1037918B1 (en) * 1997-12-11 2009-03-04 University Of Maryland Biotechnology Institute Compositions to enhance the efficacy of a vaccine using chemokines
AU759603B2 (en) * 1998-02-27 2003-04-17 Trustees Of The University Of Pennsylvania, The Vaccines, immunotherapeutics and methods for using the same
JP2002512013A (ja) * 1998-04-22 2002-04-23 カイロン コーポレイション ケモカインを使用することによる遺伝的免疫に対する免疫応答の増強

Similar Documents

Publication Publication Date Title
JP2009516529A5 (enExample)
WO2001095919A3 (en) A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
JP2009515831A5 (enExample)
WO2003011223A3 (en) Immunomodulatory compounds and methods of use thereof
WO2000050006A3 (en) Microemulsions with adsorbed macromoelecules and microparticles
DE69943170D1 (de) Immunologische Zusammensetzung und Impfstoffe, die einen auf N-Formyl-Methionyl Peptide bestehenden Adjuvans enthalten
GB0025577D0 (en) Vaccine
EP0232798A3 (en) Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
IL144671A0 (en) Immunological adjuvants compounds compositions and methods of use thereof
EP2275122A3 (en) Protein-based streptococcus pneumoniae vaccines
Nicollier-Jamot et al. Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT (R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses
CN107384944B (zh) 酵母表达的柯萨奇病毒a6病毒样颗粒及其应用
JP2006504644A5 (enExample)
WO2000062801A3 (en) Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
CA2434000A1 (en) Adjuvant viral particle
KR970703164A (ko) 헬리코박터류 감염의 치료 및 예방용 항원 제제(treatment and prevention of helicobacter infection)
JP2004505992A5 (enExample)
WO2003088995A3 (en) Mucin fusion polypeptide vaccines, compositions and methods of use thereof
WO2003007869A3 (en) Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
WO2003089584A3 (en) Use of parapox b2l protein to modify immune responses to administered antigens
JP2003534250A5 (enExample)
JPWO2021236980A5 (enExample)
JP2009501012A5 (enExample)
RU2008114841A (ru) Фармацевтическая композиция, способная индуцировать защитный иммунный ответ против вируса денге, содержащая капсидный белок этого вируса